Katie Cunningham, Growth Marketing Manager, Author at EverGlade

Katie Cunningham, Growth Marketing Manager

Katie Cunningham, Growth Marketing Manager

Inside the Genesis Mission Summit: The AI-for-Science Platform and the Funding Behind It

Leave a Comment / All Posts, DOE, Emerging Technologies, Energy, Industry News / By

The U.S. Department of Energy’s (DOE) inaugural Genesis Mission Summit brought leaders from government, research institutions, national laboratories, and industry to Washington, DC to set the direction for “AI for Science” as a national priority. Held on July 22, 2026, at the Capital Hilton, the summit confirmed that Genesis has moved well past its November 2025 Executive Order origins. […]

Inside the Genesis Mission Summit: The AI-for-Science Platform and the Funding Behind It Read More »

DARPA Announces PENG Program for Programmable Protein Engineering

Leave a Comment / All Posts, DARPA, Defense, Life Sciences / By

The Defense Advanced Research Projects Agency (DARPA) has issued a Special Notice for a new Defense Sciences Office (DSO) program, Protein ENGineering (PENG), and is hosting a hybrid Proposers Day on August 10, 2026, in Arlington, VA, with a webcast option for virtual attendees. DARPA expects to publish the full program solicitation by the end

DARPA Announces PENG Program for Programmable Protein Engineering Read More »

IARPA Launches New Solutions Marketplace for Intelligence Community Innovation 

Leave a Comment / All Posts, Emerging Technologies, Industry News / By

The Intelligence Advanced Research Projects Activity (IARPA), in partnership with The Applied Research Institute (ARI), has launched the Solutions Marketplace, a long-term, open call for innovators to share emerging technologies with the Intelligence Community (IC). Expected to open on August 1, 2026, this initiative will give companies, researchers, and startups a full year to submit

IARPA Launches New Solutions Marketplace for Intelligence Community Innovation  Read More »

NSFF: The Pentagon’s New Fund-Level Play for Critical Minerals Finance

Leave a Comment / All Posts, Defense, Energy, Industry News / By

The Department of War’s Office of Strategic Capital (OSC) has announced the National Security Fund Finance (NSFF) program, a new credit initiative aimed at shoring up U.S. critical minerals and materials that sit behind core national security technologies. Rather than adding another grant or project-level loan program for operators, NSFF routes Pentagon capital into the

NSFF: The Pentagon’s New Fund-Level Play for Critical Minerals Finance Read More »

NIH’s Unified Funding Strategy Signals a New Approach to Award Decisions

Leave a Comment / All Posts, Industry News, Life Sciences / By

The National Institutes of Health (NIH) is starting to roll out its new Unified Funding Strategy, originally announced in late 2025, to support more informed, transparent, and flexible funding decisions across its Institutes, Centers, and Offices. Peer review remains central to NIH’s process, but funding decisions will now draw on the full body of review

NIH’s Unified Funding Strategy Signals a New Approach to Award Decisions Read More »

ASPR’s New Five Year Plan: Reading the Fine Print on Medical Countermeasure Funding

Leave a Comment / All Posts, Industry News, Life Sciences / By

The Administration for Strategic Preparedness and Response (ASPR) has quietly dropped one of the most important funding documents of the year: the 2025–2029 Public Health Emergency Medical Countermeasure Enterprise (PHEMCE) Multiyear Budget (MYB). On paper, it is a five‑year budget plan across: The Administration for Strategic Preparedness and Response (ASPR) The Biomedical Advanced Research and

ASPR’s New Five Year Plan: Reading the Fine Print on Medical Countermeasure Funding Read More »

ARPA-H’s Special Notice Supports Executive Order on Serious Mental Illness and OUD

Leave a Comment / All Posts, ARPA-H, Life Sciences / By

The Advanced Research Projects Agency for Health (ARPA‑H) has released Special Notice ARPA‑H‑SN‑26‑156 under its Proactive Health Office (PHO), focusing on early clinical development of ibogaine for opioid use disorder (OUD).  This Special Notice sits under ARPA‑H’s Proactive Health Office Innovative Solutions Opening (ISO PHO‑SOL‑24‑106), which is an open solicitation for “revolutionary solutions” that do not

ARPA-H’s Special Notice Supports Executive Order on Serious Mental Illness and OUD Read More »

CDC and ASPR in the Senate Hot Seat: What the HELP Hearing Reveals About the Next Phase of U.S. Public Health 

Leave a Comment / All Posts, Industry News / By

Yesterday’s U.S. Senate Committee on Health, Education, Labor & Pensions (HELP) hearing put two key public health posts under the microscope: Sean Kaufman for Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS), and Dr. Erica Schwartz for Director of the Centers for Disease Control and Prevention

CDC and ASPR in the Senate Hot Seat: What the HELP Hearing Reveals About the Next Phase of U.S. Public Health  Read More »

HHS & VA’s MOU is Building the Data & Regulatory Backbone for Veterans’ Mental Health 

Leave a Comment / All Posts, Industry News, Life Sciences / By

The Departments of Health and Human Services (HHS) and Veterans Affairs (VA) have entered a five‑year Memorandum of Understanding (MOU) to coordinate on rapid‑acting treatments for substance use disorders and mental health conditions in veterans, including psychedelic drug products.  In parallel, the HHS/FDA and VA have signed MOU 225‑26‑007, which lays out how the agencies will collaborate and share information

HHS & VA’s MOU is Building the Data & Regulatory Backbone for Veterans’ Mental Health  Read More »

DARPA’s Perrseus Program: Manufacturable µUHV for Quantum & Atomic Sensors

DARPA’s Perrseus Program: Manufacturable µUHV for Quantum & Atomic Sensors

Leave a Comment / All Posts, DARPA, Emerging Technologies / By

The Defense Advanced Research Projects Agency (DARPA) Perrseus program is now live with a formal solicitation, moving from concept to concrete timelines and technical expectations. The goal hasn’t changed: build manufacturable, microscale ultra‑high‑vacuum (µUHV) packages that can support next‑generation quantum, MEMS, and photonics‑based sensors without relying on room‑sized vacuum systems. With the solicitation out, teams

DARPA’s Perrseus Program: Manufacturable µUHV for Quantum & Atomic Sensors Read More »

New DARPA RFI: Multiscale Reasoning Across Human Physiology

Leave a Comment / All Posts, DARPA, Life Sciences / By

The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has released RFI DARPA‑SN‑26‑100 on “Multiscale Reasoning for Human Physiology.” The agency is seeking input from organizations that can connect human biology from molecules to clinical outcomes in support of military medicine. The focus is on prediction, diagnosis, intervention, and recovery in

New DARPA RFI: Multiscale Reasoning Across Human Physiology Read More »

DTRA Topic Call 7: Advanced Bioaerosol Triggers and Engineered Genome Detection

Leave a Comment / All Posts, Defense, DTRA, Emerging Technologies / By

The Defense Threat Reduction Agency (DTRA), under the Department of Defense, has updated its FY2022–2026 Chemical / Biological Technologies Broad Agency Announcement (BAA HDTRA122S0002) with Topic Call 7, adding two new applied research topics in biological threat detection. The BAA is an open, five-year contracting vehicle focused on Technology Readiness Level (TRL) 3–6 technologies, meaning

DTRA Topic Call 7: Advanced Bioaerosol Triggers and Engineered Genome Detection Read More »

Scroll to Top